The ecological imperative: Context and timing shape the path to colorectal cancer
-
-
REFERENCES
[1] Fearon E.R. and Vogelstein B. (1990). A genetic model for colorectal tumorigenesis. Cell 61:759−767. DOI:10.1016/0092-8674(90)90186-I [2] Lourenço F.C., Sadien I.D., Wong K., et al. (2025). Decay of driver mutations shapes the landscape of intestinal transformation. Nature 649:729−738. DOI:10.1038/s41586-025-09762-w [3] Canon J., Rex K., Saiki A.Y., et al. (2019). The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature 575:217−223. DOI:10.1038/s41586-019-1694-1 [4] Maxwell M.B., Hom-Tedla M.S., Yi J., et al. (2024). ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity. Cell 187:3390−3408.e19. DOI:10.1016/j.cell.2024.04.025 [5] Martincorena I., Roshan A., Gerstung M., et al. (2015). High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348:880−886. DOI:10.1126/science.aaa6806 -
ABOUT THIS ARTICLE
Cite this article:
Duan H., Wen Z., Lei J., et al. (2027). The ecological imperative: Context and timing shape the path to colorectal cancer. The Innovation Medicine 5:100271. https://doi.org/10.59717/j.xinn-med.2027.100271
Welcome!
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Export File
Citation
Duan H., Wen Z., Lei J., et al. (2027). The ecological imperative: Context and timing shape the path to colorectal cancer. The Innovation Medicine 5:100271. https://doi.org/10.59717/j.xinn-med.2027.100271
Format
Content
DownLoad:
-
Figure 1.
Ecological "priming" dictates the trajectory of intestinal transformation
